Judge Denies Roche's Motion To Dismiss Amgen Suit
Drug maker Roche Holding AG lost its bid Friday to have biotechnology giant Amgen Inc.'s high-profile patent infringement lawsuit over blockbuster anemia drug Epogen dismissed....To view the full article, register now.
Already a subscriber? Click here to view full article